Skip to main content
OpenTrials
Completed

NCT Number: NCT04261205

Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre

A study is being carried out to evaluate the biological, technical and clinical/biological efficacy of this technique, the practice of which is standardized in the department, in order to evaluate our practices and to improve them if necessary. As part of this study, the investigators will ask all patients scheduled for this procedure to participate in this observational prospective study without changing usual practices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Failure Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

19 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nîmes, Hôpital Universitaire Caremeau

Nîmes, 30029, France

About this study

The objective of the study is to conduct a prospective evaluation of the practice of apheresis by Double Filtration System Cascade system in a university centre in current practice with evaluation of the technical and biological effectiveness as the main objective and clinical and biological tolerance as the secondary objective for all consecutive sessions performed in a university centre over a period of 1 year.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Over 18 years of age I indication for plasmapheresis and hospitalized at Chu de Nimes.

Exclusion criteria

Under guardianship or curatorship Refusal to participate

Treatment and study plan

Primary outcomes

  1. Apheresis by DFPP and biological efficiency

    Time frame: over a period of one year

    quantification of the purification carried out (volume)

Secondary outcomes

  1. Clinical side effects

    Time frame: within 1 hour of all session

    catheter dysfunction

  2. Biological side effects

    Time frame: within 1 hour of all session

    Bleeding rate

  3. variation of Hb, platelet and albumin before and after session

    Time frame: within 1 hour of all session

    % of Hb, platelet and albumin

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: DFPPSURV

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Feb 7, 2020
Registry last updated
Nov 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.